Pharmaceuticals, Biotechnology and Life Sciences
Extensive biotech finance and investor relations expertise includes leadership roles at Editas Medicine and Novartis BOSTON–(BUSINESS WIRE)–PureTech Health plc (LSE:…
Nautilus Biotechnology has entered into a definitive merger agreement with Arya Sciences Acquisition Corp III (Nasdaq: ARYA). Upon closing, the…
Extensive biotech finance and investor relations expertise includes leadership roles at Editas Medicine and Novartis CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vedanta Biosciences, a…
LEEDS, England–(BUSINESS WIRE)–4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel…
NASHVILLE, Tenn.–(BUSINESS WIRE)–#FightingCancerTogether–Today, the Sarah Cannon Transplant and Cellular Therapy Network, formerly the Sarah Cannon Blood Cancer Network, announced 19…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Q-State Biosciences, a technology-derived medicines company, today announced that it has achieved the primary program completion milestone in…
Extensive biotech finance and investor relations expertise includes leadership roles at Editas Medicine and Novartis CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vedanta Biosciences, a…
BURLINGAME, Calif.–(BUSINESS WIRE)–Humanigen, Inc. (NASDAQ:HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called…
Consistent with the 87% reduction in the first evaluable kidney biopsy, there is complete clearance of Gb3 inclusions in second…
New solutions enable enhanced delivery, tracking and management of drug safety reporting and medical questions from sites DUBLIN–(BUSINESS WIRE)–ICON plc,…